Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease

Patients with SCAD and concomitant COPD are at high risk of cardiovascular adverse events, due to chronic inflammation, responsible of endothelial dysfunction, oxidative stress and heightened platelet reactivity (PR). The objective of this randomised clinical trial was to test if ticagrelor is super...

Descripción completa

Detalles Bibliográficos
Autores principales: Campo, Gianluca, Dalla Sega, Francesco Vieceli, Pavasini, Rita, Aquila, Giorgio, Gallo, Francesco, Fortini, Francesca, Tonet, Elisabetta, Cimaglia, Paolo, Del Franco, Annamaria, Pestelli, Gabriele, Pecoraro, Alessandro, Contoli, Marco, Balla, Cristina, Biscaglia, Simone, Rizzo, Paola, Ferrari, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Schattauer GmbH 2017
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6291849/
https://www.ncbi.nlm.nih.gov/pubmed/28331925
http://dx.doi.org/10.1160/TH16-12-0973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6291849/
https://www.ncbi.nlm.nih.gov/pubmed/28331925
http://dx.doi.org/10.1160/TH16-12-0973

Ejemplares similares